Mitrix

Mitrix is developing therapies based on mitochondrial transfer, the idea that mitochondria can be delivered from outside the body and incorporated into our cells. This may be able to stave off diseases relating to mitochondrial dysfunction and to restore metabolic energy to aged cells. The company has developed bioreactors that can mass-produce such mitochondria in order to make these therapies feasible.